DD
Daniel Patrick O'Day (Chairman & CEO) filed 15 Form 4 reports in the trailing twelve months (0 purchases, 15 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $19.7M of GILD (112,429 sh across 2 lots, as filed), executed Nov 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
15
0 buys · 15 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$76.2M
shares × price, as filed
Last traded
Nov 5
Filed Nov 6
Median ADV $1.0B across their filed names
Open performance→Volume by month
Buys $0
Sells $82.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
15 filings
Sector per market data · by filing · past 12 months
Most traded names
GILDRecent filings
GILDSALE
Gilead Sciences, Inc.
View filing →
$1.1M10,000 sh across 2 lots
Exec Sep 29 2025
Filed Sep 30 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.1M
10,000 sh × $113.63
Exec Aug 28 2025
Filed Aug 29 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.1M
10,000 sh across 2 lots
Exec Jul 28 2025
Filed Jul 29 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.0M
9,400 sh × $110.40
Exec Jun 30 2025
Filed Jul 1 2025 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. View filing → $1.1M
10,000 sh across 2 lots
Exec May 30 2025
Filed Jun 2 2025 · 5:30 PM ET